Jiuzhitang Co Ltd Asset Resilience Ratio
Jiuzhitang Co Ltd asset resilience ratio. Jiuzhitang Co Ltd (000989) has an Asset Resilience Ratio of 7.86% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Jiuzhitang Co Ltd to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Jiuzhitang Co Ltd (2002–2025)
Asset resilience ratio of Jiuzhitang Co Ltd from 2002 to 2025. This chart shows how Jiuzhitang Co Ltd's Asset Resilience Ratio has changed over time. Read 000989 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Jiuzhitang Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 000989 total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥450.51 Million | 7.86% |
| Total Liquid Assets | CN¥450.51 Million | 7.86% |
Asset Resilience Insights
- Limited Liquidity: Jiuzhitang Co Ltd maintains only 7.86% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Jiuzhitang Co Ltd Industry Peers by Asset Resilience Ratio
Compare Jiuzhitang Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
Drug Manufacturers - Specialty & Generic | 11.84% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Bide Pharmatech Co. Ltd. A
SHG:688073 |
Drug Manufacturers - Specialty & Generic | 9.46% |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976 |
Drug Manufacturers - Specialty & Generic | 20.61% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.42% |
Jiuzhitang Co Ltd Asset Resilience Ratio by Year (2002–2025)
Jiuzhitang Co Ltd asset resilience ratio by year from 2002 to 2025. The table below shows the annual Asset Resilience Ratio data for Jiuzhitang Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 9.30% | CN¥505.41 Million ≈ $73.96 Million |
CN¥5.44 Billion ≈ $795.45 Million |
+3.54pp |
| 2024-12-31 | 5.76% | CN¥300.00 Million ≈ $43.90 Million |
CN¥5.21 Billion ≈ $762.60 Million |
+1.42pp |
| 2023-12-31 | 4.34% | CN¥231.20 Million ≈ $33.83 Million |
CN¥5.33 Billion ≈ $779.92 Million |
-1.60pp |
| 2020-12-31 | 5.94% | CN¥301.39 Million ≈ $44.10 Million |
CN¥5.07 Billion ≈ $742.12 Million |
-5.34pp |
| 2019-12-31 | 11.29% | CN¥553.58 Million ≈ $81.01 Million |
CN¥4.90 Billion ≈ $717.72 Million |
+7.87pp |
| 2018-12-31 | 3.41% | CN¥179.16 Million ≈ $26.22 Million |
CN¥5.25 Billion ≈ $767.94 Million |
+1.71pp |
| 2017-12-31 | 1.70% | CN¥100.00 Million ≈ $14.63 Million |
CN¥5.87 Billion ≈ $859.51 Million |
+1.64pp |
| 2010-12-31 | 0.06% | CN¥1.03 Million ≈ $150.35K |
CN¥1.74 Billion ≈ $254.40 Million |
0.00pp |
| 2009-12-31 | 0.06% | CN¥936.29K ≈ $137.01K |
CN¥1.55 Billion ≈ $226.45 Million |
-8.49pp |
| 2008-12-31 | 8.56% | CN¥132.28 Million ≈ $19.36 Million |
CN¥1.55 Billion ≈ $226.26 Million |
+7.85pp |
| 2007-12-31 | 0.70% | CN¥10.10 Million ≈ $1.48 Million |
CN¥1.44 Billion ≈ $210.96 Million |
-0.21pp |
| 2006-12-31 | 0.91% | CN¥12.56 Million ≈ $1.84 Million |
CN¥1.37 Billion ≈ $200.95 Million |
-5.04pp |
| 2005-12-31 | 5.95% | CN¥77.61 Million ≈ $11.36 Million |
CN¥1.30 Billion ≈ $190.72 Million |
+5.39pp |
| 2004-12-31 | 0.57% | CN¥7.61 Million ≈ $1.11 Million |
CN¥1.34 Billion ≈ $196.01 Million |
-0.29pp |
| 2003-12-31 | 0.86% | CN¥11.53 Million ≈ $1.69 Million |
CN¥1.34 Billion ≈ $195.70 Million |
+0.47pp |
| 2002-12-31 | 0.39% | CN¥3.95 Million ≈ $578.07K |
CN¥1.02 Billion ≈ $149.12 Million |
-- |
About Jiuzhitang Co Ltd
Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang pills, Tianma Gouteng granules, Danxi granules, and Compound Lipid-Reducing tablets for cardiovascular and neurological treatment; Nude Flower Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Zhentong … Read more